Search results for "Lux"

showing 10 items of 1464 documents

Rhombi-chain Bose-Hubbard model: Geometric frustration and interactions

2018

We explore the effects of geometric frustration within a one-dimensional Bose-Hubbard model using a chain of rhombi subject to a magnetic flux. The competition of tunnelling, self-interaction and magnetic flux gives rise to the emergence of a pair-superfluid (pair-Luttinger liquid) phase besides the more conventional Mott-insulator and superfluid (Luttinger liquid) phases. We compute the complete phase diagram of the model by identifying characteristic properties of the pair-Luttinger liquid phase such as pair correlation functions and structure factors and find that the pair-Luttinger liquid phase is very sensitive to changes away from perfect frustration (half-flux). We provide some propo…

media_common.quotation_subject/dk/atira/pure/subjectarea/asjc/2500/2504FOS: Physical sciencesFrustration02 engineering and technologyQuantum entanglementBose–Hubbard model01 natural sciencesSuperfluidityCondensed Matter - Strongly Correlated ElectronsLuttinger liquidPhase (matter)Quantum mechanics0103 physical sciences010306 general physicsPhase diagrammedia_commonPhysicsCondensed Matter::Quantum GasesQuantum PhysicsStrongly Correlated Electrons (cond-mat.str-el)/dk/atira/pure/subjectarea/asjc/3100/3104021001 nanoscience & nanotechnologyCondensed Matter PhysicsMagnetic fluxElectronic Optical and Magnetic MaterialsQuantum Gases (cond-mat.quant-gas)Condensed Matter::Strongly Correlated ElectronsQuantum Physics (quant-ph)Condensed Matter - Quantum Gases0210 nano-technology
researchProduct

Long-term monitoring of the TeV emission from Mrk 421 with the ARGO-YBJ experiment

2011

ARGO-YBJ is an air shower detector array with a fully covered layer of resistive plate chambers. It is operated with a high duty cycle and a large field of view. It continuously monitors the northern sky at energies above 0.3 TeV. In this paper, we report a long-term monitoring of Mrk 421 over the period from 2007 November to 2010 February. This source was observed by the satellite-borne experiments Rossi X-ray Timing Explorer and Swift in the X-ray band. Mrk 421 was especially active in the first half of 2008. Many flares are observed in both X-ray and gamma-ray bands simultaneously. The gamma-ray flux observed by ARGO-YBJ has a clear correlation with the X-ray flux. No lag between the X-r…

media_common.quotation_subjectAstrophysics::High Energy Astrophysical PhenomenaOggetti di tipo BL LacertaeFOS: Physical sciencesFluxAstrophysics01 natural sciences7. Clean energyindividual (Markarian 421) [BL Lacertae objects]Spectral lineGamma-rays Markarian 421 BL Lacertae Resistive Plate Chamberslaw.inventionlaw0103 physical sciencesRadiative transfer010303 astronomy & astrophysicsmedia_commonHigh Energy Astrophysical Phenomena (astro-ph.HE)Physics010308 nuclear & particles physicsMarkarian 421Settore FIS/01 - Fisica SperimentaleAstronomy and Astrophysicsgeneral [gamma ray]Synchrotron3. Good healthAir shower13. Climate actionSpace and Planetary ScienceDuty cycleSkyRaggi gammaSpectral energy distributionAstrophysics - High Energy Astrophysical Phenomena
researchProduct

Cinnamaldehyde Induces Expression of Efflux Pumps and Multidrug Resistance in Pseudomonas aeruginosa

2019

Essential oils or their components are increasingly used to fight bacterial infections. Cinnamaldehyde (CNA), the main constituent of cinnamon bark oil, has demonstrated interesting properties in vitro against various pathogens, including Pseudomonas aeruginosa. In the present study, we investigated the mechanisms and possible therapeutic consequences of P. aeruginosa adaptation to CNA. Exposure of P. aeruginosa PA14 to subinhibitory concentrations of CNA caused a strong albeit transient increase in the expression of operons that encode the efflux systems MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY/OprM. This multipump activation enhanced from 2- to 8-fold the resistance (MIC) of PA14 to …

medicine.drug_classAntibioticsMicrobial Sensitivity Testsmedicine.disease_causeCinnamaldehydeMicrobiology03 medical and health scienceschemistry.chemical_compoundAntibiotic resistanceMechanisms of ResistanceDrug Resistance Multiple BacterialOils VolatilemedicineTobramycin[CHIM]Chemical SciencesPharmacology (medical)AcroleinComputingMilieux_MISCELLANEOUS030304 developmental biologyPharmacology0303 health sciences030306 microbiologyPseudomonas aeruginosaMembrane Transport Proteins[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biologybiochemical phenomena metabolism and nutrition[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesAnti-Bacterial Agents3. Good healthCiprofloxacinMultiple drug resistanceInfectious DiseaseschemistryPseudomonas aeruginosaEffluxmedicine.drug
researchProduct

The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin

2020

The intrinsic resistance of Pseudomonas aeruginosa to polymyxins in part relies on the addition of 4-amino-4-deoxy-l-arabinose (Ara4N) molecules to the lipid A of lipopolysaccharide (LPS), through induction of operon arnBCADTEF-ugd (arn) expression. As demonstrated previously, at least three two-component regulatory systems (PmrAB, ParRS, and CprRS) are able to upregulate this operon when bacteria are exposed to colistin. In the present study, gene deletion experiments with the bioluminescent strain PAO1::lux showed that ParRS is a key element in the tolerance of P. aeruginosa to this last-resort antibiotic (i.e., resistance to early drug killing). Other loci of the ParR regulon, such as th…

medicine.drug_classOperonPolymyxinMutantMicrobial Sensitivity Testsmedicine.disease_causeMicrobiologyLipid A03 medical and health sciencesBacterial ProteinsMechanisms of ResistanceDrug Resistance BacterialmedicinePharmacology (medical)ComputingMilieux_MISCELLANEOUS030304 developmental biologyPharmacology0303 health sciencesColistin030306 microbiologyPseudomonas aeruginosaChemistryMembrane Transport ProteinsGene Expression Regulation BacterialAnti-Bacterial AgentsInfectious DiseasesRegulonPseudomonas aeruginosa[SDE]Environmental SciencesColistinlipids (amino acids peptides and proteins)EffluxGene DeletionBacterial Outer Membrane Proteinsmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Botanicals and phytochemicals from the bark of Hypericum roeperianum (Hypericaceae) had strong antibacterial activity and showed synergistic effects …

2021

Abstract Ethnopharmacological relevance Infections due to multidrug-resistant (MDR) bacteria constitute a real problem in the public health worldwide. Hypericum roeperianum Schimp. ex A. Rich (Hypericaceae) is used traditionally for treatment of various ailments such as abdominal pains, constipation, diarrhea, indigestion, nausea, and bacterial diseases. Aim of the study This study was aimed at investigating the antibacterial and antibiotic-modifying activity of the crude methanol extracts (HRB), ethyl-acetate soluble fraction (HRBa), residual material (HRBb), and 11 compounds from the bark of Hypericum roeperianum against multi-drug resistant (MDR) bacteria expressing active efflux pumps. …

medicine.drug_classTetracyclinePhytochemicalsAntibioticsMicrobial Sensitivity Tests03 medical and health sciences0302 clinical medicineDrug Resistance Multiple BacterialDrug Discoverymedicine030304 developmental biologyPharmacologyDoxycycline0303 health sciencesBacteriaTraditional medicinebiologyPlant ExtractsChemistryMembrane Transport ProteinsDrug Synergismbiology.organism_classificationAnti-Bacterial AgentsMultiple drug resistancePhytochemical030220 oncology & carcinogenesisPlant BarkEffluxAntibacterial activityHypericumBacteriamedicine.drugJournal of Ethnopharmacology
researchProduct

Role of the gastroenterologist in the management of the obese patient.

2017

Obesity is a highly prevalent disease worldwide, and one in which gastroenterologists can play an important role. Some digestive diseases are more common in obese patients, and preoperative evaluation may be required in some cases. Additionally, bariatric surgery can lead to digestive complications in the short and long term that require intervention, and endoscopic treatment can be an important factor in weight loss. The aim of this review is to highlight the role of the gastroenterologist in the management of obese patients who are either scheduled for or have undergone surgical or endoscopic treatment for obesity.

medicine.medical_specialtyBariatric SurgeryDiseaseGallstonesGastroenterologyPostgastrectomy SyndromesHelicobacter Infections03 medical and health sciences0302 clinical medicinePostoperative ComplicationsWeight lossNon-alcoholic Fatty Liver DiseaseIntervention (counseling)Internal medicinemedicineHumansEndoscopy Digestive SystemObesityStomach UlcerPhysician's RoleHelicobacter pyloribusiness.industryfungiGastroenterologyfood and beveragesDisease Managementmedicine.diseaseObesityObesity Morbid030220 oncology & carcinogenesisGastroesophageal Reflux030211 gastroenterology & hepatologyDisease Susceptibilitymedicine.symptombusinessColorectal NeoplasmsGastrointestinal HemorrhageEndoscopic treatmentGastroenterologia y hepatologia
researchProduct

Improving opportunities for effective management of gastro-oesophageal reflux disease

2002

The recent introduction of proton pump inhibitors has extraordinarily improved the therapeutic approach to gastro-oesophageal reflux disease. The concept of decreasing gastric acid secretion and increasing the pH in the lower oesophagus has been demonstrated to be therapeutically effective and the higher the level of pH achieved, the better the results. In spite of the evident efficacy of these molecules, there are still many patients who will continue to have symptoms despite medical treatment. Proton pump inhibitors suppress gastric acidity, but this effect shows a remarkable interindividual variation depending on different reasons. Thus, it is still possible to optimise medical therapy f…

medicine.medical_specialtyBiological AvailabilityDiseaseGastroenterologyEsomeprazoleTherapeutic approachIsomerismInternal medicineEsophagitisHumansMedicineOmeprazoleHepatologybusiness.industrydigestive oral and skin physiologyGastroenterologyRefluxEsomeprazoleProton Pump InhibitorsHydrogen-Ion ConcentrationAnti-Ulcer Agentsdigestive system diseasesClinical trialTreatment OutcomeTolerabilityGastric MucosaGastroesophageal RefluxGastric acidbusinessOmeprazolemedicine.drugDigestive and Liver Disease
researchProduct

Progression of Gastric Acid Production in Preterm Neonates: Utilization of In-vitro Method

2018

Background: There have been limited studies done regarding ability to produce gastric acid in preterm infants. Most studies have used in vivo method of assessing gastric pH. Objectives: The objectives of the study was to assess the feasibility of using an in vitro method of measuring gastric pH in babies ≤ 28 weeks gestational age (GA) and determine whether changes in gastric pH differ with gestational age, mode of delivery, and use of antenatal steroids. Design/Methods: Prospective study that enrolled extremely low birth weight (ELBW) babies. Gastric aspirate was collected before feeding. In vitro testing of gastric aspirates for pH were done on days of life 1, 3, 5, 7, 14, and 28 by using…

medicine.medical_specialtyBirth weightCoefficient of variationInvitro methodGastroenterologypH meterprogression of acidity03 medical and health sciences0302 clinical medicine030225 pediatricsInternal medicinemedicinepreterm infantsProspective cohort studygastric pHbusiness.industrylcsh:RJ1-570Gestational ageRepeated measures designlcsh:PediatricsLow birth weight030220 oncology & carcinogenesisPediatrics Perinatology and Child HealthGastric acidrefluxmedicine.symptombusinessFrontiers in Pediatrics
researchProduct

Gastroesophageal Reflux and Bleeding Esophageal Varices

1979

The incidence of gastroesophageal reflux was evaluated with the use of a pH probe in 12 patients with cirrhosis and recent variceal hemorrhage and in 15 healthy control subjects. Short episodes of reflux occurred in 42% of the patients and in 47% of the controls. During an observation period of 1 hr, the cumulative duration of reflux was similar in patients (2.5 ± 1.3 min) and controls (3.1 ± 1.4 min). Mean lower esophageal sphincter pressures were normal in both groups but did not show a significant correlation with the duration of reflux. These data support previous observations that gastroesophageal reflux does not appear to be a contributing factor in the development of variceal hemorrh…

medicine.medical_specialtyCirrhosisHepatologybusiness.industryIncidence (epidemiology)digestive oral and skin physiologyGastroenterologyRefluxVariceal hemorrhagemedicine.diseaseGastroenterologydigestive system diseasesInternal medicineHealthy controlmedicineBleeding esophageal varicesEsophageal sphincterIn patientbusinessGastroenterology
researchProduct

Cromakalim inhibits electrically-evoked [3H]acetylcholine release from a tube-preparation of the rat isolated trachea by an epithelium-dependent mech…

1993

Rat isolated tracheae were labelled by incubation with [3H]choline to measure the tritium efflux elicited by electrical stimulation of the extrinsic parasympathetic nerves in vitro. Stimulated tritium efflux reflects the neuronal release of newly synthesized acetylcholine; the effects of potassium channel openers on the stimulated tritium efflux were investigated. In tracheae opened longitudinally neither cromakalim nor its 3S,4R-enantiomer, BRL 38227, reduced the stimulated tritium efflux, whereas in intact tube-preparations cromakalim (0.01-1 mumol/l) mediated a concentration-dependent inhibition. The inhibitory effect of 1 mumol/l cromakalim was prevented by 0.1 mumol/l glibenclamide. Li…

medicine.medical_specialtyCromakalimPotassium ChannelsStimulationIn Vitro TechniquesEpitheliumGlibenclamidechemistry.chemical_compoundInternal medicinemedicineAnimalsBenzopyransPyrrolesPharmacologyStereoisomerismGeneral MedicinePotassium channelAcetylcholineRatsTracheaEndocrinologyMechanism of actionchemistrycardiovascular systemBiophysicsLiberationEffluxmedicine.symptomCromakalimAcetylcholinemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct